Audits & Inspection
Audits and regulatory inspections are where a quality system is tested under pressure. This pillar covers building a genuine state of control, internal audit programs, FDA and EMA inspection dynamics, and how to respond to Form 483 observations and warning letters in a way that holds up.
13 articlesAudit Finding Classification: Critical, Major, Minor and the Evidence Behind Each
How GxP audit and inspection findings are graded into critical, major and minor categories, the regulatory basis for each tier, and how to substantiate a finding with objective evidence.
How to Conduct a Supplier or GMP Audit: Planning, Agenda, Observations, and the Report
A working method for auditor fieldwork: scoping and planning the audit, running the opening meeting, sampling records, gathering evidence, grading findings, writing the report, and closing CAPA.
FDA Inspection Readiness: Building and Maintaining a State of Control
What FDA inspection readiness actually means: not a sprint before an announced visit, but maintaining systems that would survive one at any time. Covers inspection types, front room and back room operations, SME preparation, and how data integrity is assessed.
Internal Audit Program: Planning, Executing, and Following Up
How to design and run a GxP internal audit and self-inspection program: the risk-based annual schedule, auditor qualification, audit preparation and execution techniques, finding classification, CAPA linkage, and how to make internal audits genuinely useful rather than performative.
Running a Mock Inspection: Designing a Dry Run That Surfaces Real Gaps
How to scope, staff, run, score, and remediate a mock regulatory inspection so it finds the gaps a real inspector would, not a feel-good rehearsal.
Regulatory Intelligence: Mining 483s, Warning Letters, and EIRs to Stay Ahead
How to build a regulatory intelligence function that systematically tracks FDA 483s, warning letters, EIRs, and overseas inspection reports, then feeds the patterns into CAPA, risk assessment, and SOP change impact.
Regulatory Reporting Obligations and Their Clocks
A decision-tree reference for when a Field Alert Report, Biological Product Deviation Report, expedited adverse-event report, or recall notification is triggered, who decides, the regulatory clock for each, and the record that proves you met it.
FDA Form 483 and Warning Letters: How to Respond Effectively
What FDA 483 observations actually mean, what makes a response effective rather than inadequate, and how to structure a Warning Letter remediation that closes the matter rather than escalating it.
FDA 483 and Warning Letter Responses: Strategy, Structure, and What Actually Works
How to structure an FDA 483 response that closes observations: root cause depth, CAPA commitments, realistic timelines, data integrity handling, and the difference between responses that work and responses that escalate.
FDA vs. EMA Inspections: Strategic Differences Every Compliance Leader Should Know
A practitioner's comparison of FDA and EU GMP inspection approaches: how they differ in agency structure, investigator authority, notification, scope, data integrity technique, deficiency classification, and enforcement. Written for compliance leaders managing facilities across both jurisdictions.
Managing Health Authority Interactions: Pre-IND, Type A/B/C Meetings, and Information Requests
A working guide to FDA and EMA meeting types, briefing books, scientific advice, and how to handle deficiency letters and complete response letters without losing the program.
Inspection Readiness: How to Demonstrate a Genuine State of Control
What inspection readiness actually means, how to prepare a site for FDA or EMA inspection without theater, what inspectors look for, and how front room and back room operations work in practice.
Managing a Live FDA or EMA Inspection: Front Room, Back Room, Scribes, and SME Conduct
How to run the front room and back room during a live FDA or EMA inspection, with runner and scribe roles, document control, SME conduct rules, and daily wrap-ups.